RecruitingPhase 3NCT07037433Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesitySponsor: AmgenDaphne, AL · Fairhope, AL · Huntsville, AL · +137 more sites
RecruitingPhase 2NCT07783802A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular EventSponsor: Eli Lilly and CompanyHuntsville, AL · +29 more sites
RecruitingPhase 3NCT07784270A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightSponsor: AstraZenecaFairhope, AL · Huntsville, AL · Mobile, AL · +51 more sites
RecruitingPhase 3NCT07037459Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesitySponsor: AmgenBirmingham, AL · Dothan, AL · Fairhope, AL · +118 more sites
RecruitingPhase 3NCT07743450A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesSponsor: Ascletis Pharma (China) Co., LimitedBirmingham, AL · Huntsville, AL · +82 more sites